1,210
Participants
Start Date
June 30, 2001
Primary Completion Date
April 30, 2004
Study Completion Date
April 30, 2004
carvedilol
metoprolol
GSK Investigational Site, Panama City
GSK Investigational Site, St. Petersburg
GSK Investigational Site, Indianapolis
GSK Investigational Site, Elkhart
GSK Investigational Site, Oak Park
GSK Investigational Site, Kalamazoo
GSK Investigational Site, Iowa City
GSK Investigational Site, Milwaukee
GSK Investigational Site, Madison
GSK Investigational Site, Minneapolis
GSK Investigational Site, Chicago
GSK Investigational Site, O'Fallon
GSK Investigational Site, St Louis
GSK Investigational Site, St Louis
GSK Investigational Site, Kansas City
GSK Investigational Site, Kansas City
GSK Investigational Site, Oklahoma City
GSK Investigational Site, The Colony
GSK Investigational Site, Dallas
GSK Investigational Site, Fort Worth
GSK Investigational Site, San Antonio
GSK Investigational Site, San Antonio
GSK Investigational Site, Georgetown
GSK Investigational Site, Midland
GSK Investigational Site, Aurora
GSK Investigational Site, Denver
GSK Investigational Site, Golden
GSK Investigational Site, Idaho Falls
GSK Investigational Site, Ogden
GSK Investigational Site, Phoenix
GSK Investigational Site, Phoenix
GSK Investigational Site, Glendale
GSK Investigational Site, Tucson
GSK Investigational Site, Albuquerque
GSK Investigational Site, Las Vegas
GSK Investigational Site, Long Beach
GSK Investigational Site, Pasadena
GSK Investigational Site, Spring Valley
GSK Investigational Site, Encinitas
GSK Investigational Site, San Diego
GSK Investigational Site, Riverside
GSK Investigational Site, Hemet
GSK Investigational Site, Orange
GSK Investigational Site, San Luis Obispo
GSK Investigational Site, Burlingame
GSK Investigational Site, Concord
GSK Investigational Site, Honolulu
GSK Investigational Site, Oregon City
GSK Investigational Site, Bend
GSK Investigational Site, Renton
Lead Sponsor
GlaxoSmithKline
INDUSTRY